Results 141 to 150 of about 21,936 (207)

Safety and Efficacy Comparison of Ticagrelor versus Other P2Y12 Inhibitors in Combination with Oral Anticoagulants as a Part of DAPT/SAPT in Patients with Concomitant Atrial Fibrillation and Coronary Artery Disease: A Meta-Analysis. [PDF]

Ther Clin Risk Manag
Li Y, Gong J, Liu N.
europepmc   +1 more source

P2Y12 Inhibitor or Aspirin Monotherapy for Chronic Coronary Disease: A Nationwide Cohort Study. [PDF]

Cardiovasc Ther
Baik M, Jeon J, Yoo J, Kim J.
europepmc   +1 more source

Challenges and prospects of <i>CYP2C19</i> genotype-guided clopidogrel therapy from the perspective of precision medicine. [PDF]

Front Pharmacol
Wang Z, Fu X, Zhang G.
europepmc   +1 more source

Response to the response to the letter: "The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI and receiving abciximab". [PDF]

Cardiol J
Umińska JM.
europepmc   +1 more source

Current Strategies for Optimizing Antithrombotic Therapy in Patients with Chronic Coronary Syndrome: A Dynamic Approach. [PDF]

TH Open
Selvarajah A, Fabris E, van Leeuwen MAH, Van't Hof A, Hermanides R.   +4 more
europepmc   +1 more source

Association between preoperative interruption of antiplatelet therapy and postoperative thrombotic risk after minimally invasive surgery for abdominopelvic cancer in patients treated with P2Y12 inhibitors. [PDF]

BMC Med
Kubota M, Yoshida S, Goto T, Fukasawa T, Anno T, Fujiwara G, Toshiyama S, Inayama Y, Yanai T, Sumiyoshi T, Saito R, Kobayashi T, Kawakami K.   +12 more
europepmc   +1 more source

Macrophage Iron Metabolism Mediates Immunometabolic Reprogramming and Tissue Homeostasis: From Molecular Mechanisms to Clinical Translation. [PDF]

Cells
Wang M, Wang M, Ying Q, Li Q, Lou X, Dai S, Liu Z.   +6 more
europepmc   +1 more source

The polypill after acute coronary syndrome: A feasible pill to swallow? [PDF]

Am J Prev Cardiol
Khan SU, Patel KV.
europepmc   +1 more source